Evaluation of New Diagnostic Methods of Cardio-embolic Related (Atrial Fibrillation) Cerebral Infarction

Hopital Foch1 site in 1 country27 target enrollmentJune 13, 2016

ConditionsStroke

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Stroke
Sponsor: Hopital Foch
Enrollment: 27
Locations: 1
Primary Endpoint: Number of patients with subdiaphragmatic infarctions detected by abdominal MRI
Status: Terminated
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The aim of the study is to estimate the contribution of abdominal imaging by magnetic resonance Imaging (MRI) and abdominal scanner in the detection of subdiaphragmatic infarction associated to the atrial fibrillation in the cerebral infarction.

Registry

clinicaltrials.gov

Start Date

June 13, 2016

End Date

December 2020

Last Updated

5 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Hopital Foch

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patient over 18
•Patient having a CHADS-VAsc Score ≥ 2;
•Patient hospitalized for a secondary established ischemic accident in an atrial fibrillation not anticoagulated (INR\<2 and/or receiving antiplatelet (aspirin, clopidogrel)) for less than 14 days;
•Patient affiliated to a national insurance scheme or beneficiary
•Patient having given a written consent

Exclusion Criteria

•Patient presenting cognitive disorders incompatible with the planned examinations (MRI / SCANNER).
•Pacemaker or implantable defibrillator, or other contraindication in the MRI (metallic eye brightness, intra cerebral clip).
•Contraindication in injected scanner.
•Current pregnancy